Fortress Biotech Inc (NASDAQ: FBIO) on Monday, soared 13.09% from the previous trading day, before settling in for the closing price of $2.75. Within the past 52 weeks, FBIO’s price has moved between $1.33 and $4.20.
During the last 5-year period, the sales growth of Healthcare Sector giant was 24.49%. The company achieved an average annual earnings per share of 63.20%. With a float of $23.02 million, this company’s outstanding shares have now reached $29.75 million.
Let’s determine the extent of company efficiency that accounts for 101 employees.
Fortress Biotech Inc (FBIO) Insider Activity
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Fortress Biotech Inc is 22.61%, while institutional ownership is 16.67%. The most recent insider transaction that took place on May 29 ’25, was worth 129,000. In this transaction 10% Owner of this company sold 100,000 shares at a rate of $1.29, taking the stock ownership to the 6,122,249 shares.
Fortress Biotech Inc (FBIO) Earnings and Forecasts
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.76 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.27) by -0.49. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.67 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 63.20% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 9.86% during the next five years compared to 24.49% growth over the previous five years of trading.
Fortress Biotech Inc (NASDAQ: FBIO) Trading Performance Indicators
Fortress Biotech Inc (FBIO) is currently performing well based on its current performance indicators. A quick ratio of 1.70 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.56.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.14, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.90 in one year’s time.
Technical Analysis of Fortress Biotech Inc (FBIO)
Looking closely at Fortress Biotech Inc (NASDAQ: FBIO), its last 5-days average volume was 3.0 million, which is a jump from its year-to-date volume of 0.5 million. As of the previous 9 days, the stock’s Stochastic %D was 32.30%.
During the past 100 days, Fortress Biotech Inc’s (FBIO) raw stochastic average was set at 57.25%, which indicates a significant increase from 43.81% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.34 in the past 14 days, which was higher than the 0.17 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.77, while its 200-day Moving Average is $2.03. However, in the short run, Fortress Biotech Inc’s stock first resistance to watch stands at $3.27. Second resistance stands at $3.44. The third major resistance level sits at $3.71. If the price goes on to break the first support level at $2.83, it is likely to go to the next support level at $2.56. Should the price break the second support level, the third support level stands at $2.39.
Fortress Biotech Inc (NASDAQ: FBIO) Key Stats
Market capitalization of the company is 92.54 million based on 29,755K outstanding shares. Right now, sales total 57,680 K and income totals -46,000 K. The company made 16,410 K in profit during its latest quarter, and 15,490 K in sales during its previous quarter.
